Glycolipid Disialoganglioside-directed Antibody [EPC] class drugs

3 results

  • danyelza - naxitamab injection

    (Naxitamab)
    Y-Mabs Therapeutics, Inc.
    Danyelza, with GM-CSF, treats pediatric patients (1 year and older) and adults with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who showed partial, minor, or stable response to prior therapy.
    Medication Details
    Drug Interactions

  • unituxin - dinutuximab injection

    (Dinutuximab)
    United Therapeutics Corporation
    Unituxin (dinutuximab), used with GM-CSF, IL-2, and 13-cis-retinoic acid, treats pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy.
    Medication Details
    Drug Interactions